---
layout: post
title: "Request for Nominations From Industry Organizations Interested in Participating in the Selection Process for Nonvoting Industry Representatives and Request for Nominations for Nonvoting Industry Representatives on the Vaccines and Related Biological Products Advisory Committee"
date: 2026-02-05 18:56:45 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-19496
original_published: 2023-09-11 00:00:00 +0000
significance: 8.00
---

# Request for Nominations From Industry Organizations Interested in Participating in the Selection Process for Nonvoting Industry Representatives and Request for Nominations for Nonvoting Industry Representatives on the Vaccines and Related Biological Products Advisory Committee

**Published:** February 05, 2026 18:56 UTC
**Source:** Federal Register
**Original Published:** September 11, 2023 00:00 UTC
**Document Number:** 2023-19496

## Summary

The Food and Drug Administration (FDA or Agency) is requesting that any industry organizations interested in participating in the selection of nonvoting industry representatives to serve on the Vaccines and Related Biological Products Advisory Committee (VRBPAC) for the Center for Biologics Evaluation and Research notify FDA in writing. FDA is also requesting nominations for a nonvoting industry representative(s) to serve on the VRBPAC. A nominee may either be self- nominated or nominated by an organization to serve as a nonvoting industry representative. Nominations will be accepted for current vacancies effective with this notice.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/09/11/2023-19496/request-for-nominations-from-industry-organizations-interested-in-participating-in-the-selection)
- API: https://www.federalregister.gov/api/v1/documents/2023-19496

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
